Press Releases

Date Title and Summary
Toggle Summary M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients
SUNNYVALE, Calif., Oct. 26 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the company is partnering with The University of Texas M. D. Anderson Cancer Center in Houston, Texas to launch a prospective clinical study
Toggle Summary U.S. Government Purchases CyberKnife(R) System for Houston VA Hospital
First Government Contract Allows Greater Access to the Benefits of Radiosurgery SUNNYVALE, Calif., Oct. 24 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the U.S. Government has purchased a CyberKnife(R) Robotic
Toggle Summary Accuray Incorporated to Host Investor and Analyst Meeting at ASTRO 2007
Live Webcast on Monday, October 29 at 5:00 p.m. PDT (8:00 p.m. EDT) SUNNYVALE, Calif., Oct. 23 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that it will host an investor and analyst meeting in conjunction with the 49th
Toggle Summary Accuray Incorporated to Report First Quarter Fiscal Year 2008 Financial Results
SUNNYVALE, Calif., Oct. 12 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that it will report results for its first quarter fiscal year 2008, ending September 29, 2007, on Wednesday, November 7, 2007 after the market
Toggle Summary Hospital Corporation of America Purchases Seventh CyberKnife(R) System
Most Recent Purchase for Installation in United Kingdom SUNNYVALE, Calif., Oct. 4 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that leading healthcare services company, Hospital Corporation of America (HCA), has
Toggle Summary Accuray to Webcast Senior Management Presentations at Analyst Day Event
SUNNYVALE, Calif., Oct 02, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that it will provide a live webcast for its first ever Analyst Day event, and media and investors are invited to
Toggle Summary CyberKnife(R) System Shows Momentum as Treatment Option for Prostate Cancer
Accuray Achieves Patient Treatment Milestone on Third Anniversary of National Prostate Cancer Awareness Month SUNNYVALE, Calif., Sept. 25 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that more than 1,000 men have been
Toggle Summary Accuray Incorporated's CEO to Speak at UBS Global Life Sciences Conference
SUNNYVALE, Calif., Sept. 24 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its president and CEO, Euan S. Thomson, Ph.D., is scheduled to present a corporate update at the UBS Global Life Sciences Conference at the
Toggle Summary Accuray Receives FDA Clearance for New Dose Calculation Technique for Body Radiosurgery
Worldwide Availability of Monte Carlo Dose Calculation Software Announced at European Radiation Oncology Meeting in Barcelona BARCELONA, Spain, Sept. 10 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its Monte Carlo
Toggle Summary Accuray Board Approves Stock Repurchase Plan
SUNNYVALE, Calif., Aug. 30 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), today announced that its Board of Directors has approved a plan that authorizes the Company to repurchase shares of its common stock. Under the plan, the Company will have the ability to acquire up to $25

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.